For Comments , Questions or to suggest a news feature please contact :
Cannabis Stocks News
Copyright 2016 Cannabis Stocks News
Cannabis Stocks News is an independent paid circulation newsletter and advertising supported news report produced by Cannabis Stocks News and NWBB Inc. . This paid advertising issue  does not purport to provide an analysis of any company’s financial position or prospects and this is not to be construed as a recommendation by Cannabis Stocks News and NWBB Inc. and is not in any way to be construed as an offer or solicitation to buy or sell any security. Although the information contained in this advertisement is believed to be reliable, Cannabis Stocks News  and its editors make no warranties as to the accuracy of the description of any of the content herein and accept no liability for how readers or listeners  may choose to use it. Cannabis Stocks News and NWBB Inc. , including any of our principals, officers, directors, partners, agents, or affiliates are not, nor do we represent ourselves to be, registered investment advisors, brokers, or dealers in securities. Readers and listeners should independently verify all statements made in this advertisement. Product names, logos, brands, and other trademarks featured or referred to within this presentation and online report are the property of their respective trademark holders. These trademark holders are not affiliated with Cannabis Stocks News and NWBB Inc. The radio broadcast and online report, and the opinions of those quoted within are for informational and advertising purposes only. Speculation in securities carries a high degree of risk, and investors purchasing speculative investments should be capable of absorbing losses of all of their invested capital. There is no assurance that the featured company will receive additional funding or experience any future development necessary for corporate success. Information contained in the broadcast  and online report contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, including statements regarding the expected continual growth of the market for the company’s products, the company’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions, or future events or performance may be forward-looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward-looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur. Past investment performance is not in any way indicative of future investment performance. Readers must consult with registered professional investment, taxation, and portfolio advisors before making an investment decision. The broadcast and online report are not a solicitation for subscriptions. The companies or “Company” or “Companies” or “Profiled Company” or “Profiled Companies”), the company featured in this report, appears as paid advertising,
Delivering News On Public Companies Within The Cannabis Sector

Subscribe to The News

The Cannabis Stocks Newsletter
A free weekly cannabis news report
Freedom Leaf  ( FRLF ) Acquires Tierra Science Global Year 1 Revenues for New Subsidiary Projected in Excess of $2,500,000.00
Freedom Leaf, Inc. (OTCQB:FRLF), a Company dedicated to health and wellness products derived from legal Hemp and comprised of a group of diversified, international, vertically-integrated hemp businesses and cannabis media companies, is pleased to announce that it has consummated a 100% acquisition of Tierra Science Global, LLC, a company specializing in health supplements supporting peak bio-energy levels in humans which are currently distributed via highly motivated direct sales teams and well established affiliate programs in Europe, Asia and the United States. Tierra Science Global ("Tierra") is led by founding managers, Mark Rolando Rosales and Marc Viterillo. Rosales has over 25 years of success in direct sales and network marketing, while Viterillo is a software development expert with extensive experience in online sales. Tierra has already achieved in excess of $500,000 in revenues from January to June of 2018 with its existing product line, which include premium supplements focused on increase of mental stamina, athletic performance and protection from harmful effects of Electromagnetic fields produced by cell phones, laptops, gaming consoles and other devices. Freedom Leaf will take the brand and potential revenues one significant step further by manufacturing a number of unique Full Spectrum Hemp/CBD oil products including two skin serums by renown Beverly Hills Anti-Aging Practitioner, Dr. Naina Sachdev (NAINAMD), who most recently served as the Ambassador for Procter & Gamble Olay's Regenerist skincare line internationally is also ABAARM certified Medical Director at NAINAMD(TM) Anti-Aging & Regenerative Clinic in Beverly Hills, CA and affiliate clinics with her current international client base from Beverly Hills to Dubai. Manufacturing will be done by Freedom Leaf's wholly-owned subsidiary, IRIE CBD Medicinals and will include the launch of an assertive affiliate marketing campaign to market and distribute Tierra branded products such as pain cream, calming tinctures, honey sticks and more to meet ever increasing demand for these products worldwide. According to Forbes, the CBD market will grow to $2.1 billion by 2020, an astronomical jump from last year's CBD market of $202 million. Matt Karnes of Greenwave Advisors is even more optimistic about the growth of the CBD market saying, "In terms of the CBD market size, I estimate an almost $3 billion market by 2021.
Right now there are 15 states that allow CBD only -- this is in addition to the 28 states plus DC that have legalized medical marijuana." Freedom Leaf CEO, Cliff Perry is confident that Tierra will achieve new revenue highs expeditiously toward additional profits and increase in shareholder value. "The affiliate model we are deploying for Tierra is expected to yield 150 product packages per week at an average price of $400 each, yielding $240,000 per month in revenues with a 24% net profit. This would equate to $57,600 in profits from the affiliate model alone with conservative estimates for $2.88 million in yearly revenues," states Perry. More to come on this exciting venture from Freedom Leaf execs in the coming days, including details on Tierra's official pre-launch of the affiliate program to be accompanied by live worldwide broadcasts via Zoom on August 11(th) and 12(th) 2018. Freedom Leaf, Inc. (OTCQB:FRLF) is a group of diversified, international, vertically-integrated hemp businesses concentrating on health, wellness, and education as well as cannabis media companies. FRLF is building a diverse portfolio of valuable businesses through strategic mergers, acquisitions, and acceleration projects across the industry. FRLF's large portfolio of acquisitions and properties includes: our recently acquired full spectrum hemp oil product line - Irie CBD; our wholly-owned hemp extraction division - Leafceuticals, Inc.; our exclusive health and wellness full spectrum hemp oil brand - Hempology, our just-acquired indoor hemp greenhouse in Valencia, Spain for the cultivation of Hemp; our hemp-based rolling paper company - Plants to Paper; two of the largest Spanish-speaking cannabis web portals in the world - and, and of course our flagship publication - Freedom Leaf Magazine. Utilizing these mergers and acquisitions, Freedom Leaf, Inc. is continually building a solid foundation for our vertically-integrated hemp company to maximize both revenue growth, and net profit, which will increase our shareholders value. Our cultivation and extraction divisions allow FRLF to grow and source our own hemp CBD, which allows dramatically lower production costs for our wholly- owned CBD product lines, thereby generating more revenue for each product sold. We formulate and manufacture the majority of our products in our own in-house formulation centers, also greatly reducing our costs and increasing revenue. This is a republished version of the 8/1/18 GlobeNewswire p[res release issued by Freedom Leaf Inc.
For Comments , Questions or to suggest a news feature please contact:
Have A Story Idea?